13F filer · CIK 2052213
Elmind Capital, LP
NEW YORK, NY · filing since Q4 2025 · last filing Aug 14, 2026
Reported value
$352.2M
+$13.4M vs prior
Positions
34
New / sold out
2 / 2
Added / reduced
7 / 6
Turnover
12.2%
buys $42.0M · sells $49.0M
Top-10 weight
68.8%
Biggest buys vs Q4 2025
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | CYTOMX THERAPEUTICS INC. | +3,850,000 | +550.0% | +$18.1M |
| New | DBV TECHNOLOGIES S A | +265,000 | – | +$5.5M |
| Added | KALVISTA PHARMACEUTICALS INC | +220,000 | +27.5% | +$4.4M |
| Added | CULLINAN THERAPEUTICS INC | +220,000 | +71.0% | +$3.1M |
| New | ALUMIS INC | +130,000 | – | +$2.9M |
| Added | UNITED THERAPEUTICS CORP DEL | +4,000 | +36.4% | +$2.4M |
| Added | UROGEN PHARMA LTD | +120,000 | +120.0% | +$2.2M |
| Added | TRAVERE THERAPEUTICS INC | +67,600 | +61.5% | +$2.0M |
| Added | VAXCYTE INC | +25,000 | +8.6% | +$1.5M |
Biggest sells vs Q4 2025
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | CG ONCOLOGY INC | -200,700 | -40.8% | $-13.6M |
| Reduced | BIOCRYST PHARMACEUTICALS INC | -1,150,000 | -53.5% | $-10.9M |
| Sold out | DYNAVAX TECHNOLOGIES CORP | -679,900 | -100.0% | $-10.5M |
| Reduced | VIRIDIAN THERAPEUTICS INC | -323,700 | -37.7% | $-6.3M |
| Sold out | LIQUIDIA CORPORATION | -90,000 | -100.0% | $-3.1M |
| Reduced | BIOMARIN PHARMACEUTICAL INC | -35,000 | -42.7% | $-2.0M |
| Reduced | WAVE LIFE SCIENCES LTD | -270,000 | -60.3% | $-2.0M |
| Reduced | EDGEWISE THERAPEUTICS INC | -20,000 | -66.7% | $-630.0K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q1 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | COGENT BIOSCIENCES INCCOM | 1,170,740 | $45.1M | 12.79% |
| 2 | SYNDAX PHARMACEUTICALS INCCOM | 1,855,000 | $43.3M | 12.30% |
| 3 | CELLDEX THERAPEUTICS INC NEWCOM NEW | 865,000 | $27.4M | 7.79% |
| 4 | CYTOMX THERAPEUTICS INC.COM | 4,550,000 | $21.4M | 6.07% |
| 5 | KALVISTA PHARMACEUTICALS INCCOM | 1,021,300 | $20.6M | 5.84% |
| 6 | CG ONCOLOGY INCCOM | 291,800 | $19.7M | 5.61% |
| 7 | VERA THERAPEUTICS INCCL A | 482,500 | $19.4M | 5.51% |
| 8 | VAXCYTE INCCOM | 316,500 | $18.4M | 5.22% |
| 9 | PHARVARIS N VCOM | 475,750 | $13.4M | 3.82% |
| 10 | TYRA BIOSCIENCES INCCOM | 350,000 | $13.4M | 3.81% |
24 more rows. Subscribe for $29/month to see every row, download the data and use the API.